1[2]George M. Eliopoulos,Robert C. Moellering. Azlocillin,Mezlocillin, and Piperacillin: new broad-spectrum penicillins.Annals of Intenal Medicine. 1982,97 : 755-760.
6[7]Laura J V. Piddock,YU Fang Jin, HL. Turner. Activity of 13 β- lactam agents combined WithBRL42715againstp- lactamaseproducingGram- negativebacteriacomparedto combinations with clavulanic acid, tazobactam and sulbatam. J Antimicro Chemother. 1993,31: 89- 103.
7[8]Wildfeuer-A,Schmalreck- A,Rader-K,et al. Studies on the synergism of sulbactam and - lactam antibiotics underin Vitro conditions andin healthy volunteers after intravenous administration. Drug Res. 1989,39(1):94-100.
8[9]Schmalreck AF, Wildfeuer A. In vitro activity against Clinically important gram - positve andgram - negativebacteria of Sulbactam, alone andincombination With ampicillin, cefotaxime, mezlocillin, andpiperacillin. Arzneimittelforschung.1990,40(10) : 1145 - 1155.
9[10]Manncke K, Springsklee M, Heizmann WR, et al. SUlbactam incombinationwithmezlocillin, piperacillin Orcefotaxime.Clinical and hacteriological resultS in the treatment of severe bacterial ifections. Med - Klin, 1991,15; 86 (9): 454- 460.
10[11]Bauemfeind- A, Grimm- H, Klietmann-W, et al. The effect of SUlbactam on the in Vitroactivity Of mezlocillin,piperacillin,and cefotaxime. Arzneimittelforschung. 1991; 41(8) :831 - 831.
10A. M. Emmerson,D. A. Cox,L. J. Lees.Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid[J].European Journal of Clinical Microbiology.1983(4)
